The first 10 drugs selected for price negotiation under the Inflation Reduction Act (IRA) have been officially named by the Centers for Medicare and Medicaid Services (CMS). While some of the choices were expected, a few came as a surprise. The IRA set specific criteria for Medicare-covered drugs eligible for negotiation. The drugs had to …
The Centers for Medicare and Medicaid Services (CMS) made an exciting announcement on Tuesday, revealing the first 10 drugs that have been selected for Medicare price negotiation under the Inflation Reduction Act (IRA). These drugs were chosen based on their eligibility under the IRA and their status as the highest-cost drugs covered by Medicare Part …
The Department of Justice (DOJ) has strongly criticized the Chamber of Commerce’s request for an injunction to block the Medicare drug price negotiation program. In court filings, the DOJ argued that the Chamber had no standing to file the lawsuit and that pausing the program would harm the public. The federal government is expected to …
The U.S. Chamber of Commerce, known as one of the largest lobbying groups in the country, has taken legal action to prevent the implementation of the Medicare Drug Price Negotiation program, established by the Inflation Reduction Act (IRA). This program has been met with numerous legal challenges, and the Chamber filed a lawsuit last month …
The Centers for Medicare and Medicaid Services (CMS) have announced revisions to their guidance for the Medicare drug price negotiation program, which was established under the Inflation Reduction Act (IRA). These changes appear to be a response to multiple lawsuits challenging the program’s constitutionality. The negotiations for the Medicare Drug Price Negotiation Program are scheduled …
The largest lobbying group in the pharmaceutical industry, the Pharmaceutical Research and Manufacturers of America (PhRMA), has filed a lawsuit challenging certain provisions in the Biden administration’s Inflation Reduction Act. These provisions allow Medicare to negotiate prices for specific drugs. The lawsuit, filed in the U.S. District Court for the Western District of Texas, argues …
Bristol Myers Squibb (BMS), a leading U.S. pharmaceutical company, has joined the growing list of organizations filing a legal challenge against the Medicare drug price negotiation program established by the Inflation Reduction Act (IRA). In line with similar complaints filed by Merck & Co. and the Chamber of Commerce, BMS argues that the provision in …
The U.S. Chamber of Commerce has filed a lawsuit against the Biden administration over the Medicare price negotiation provisions in the Inflation Reduction Act. Merck also filed a lawsuit earlier this week, making the Chamber of Commerce the second organization to challenge the measure. In a statement, the Chamber of Commerce argued that government price …